


Ask a doctor about a prescription for Biofenac
Aceclofenac
Biofenac is a pain-relieving and anti-inflammatory medicine.
Biofenac is used to treat chronic joint diseases associated with chronic pain and inflammation, such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.
Before starting treatment with Biofenac, discuss it with your doctor:
Taking medicines like Biofenac may be associated with an increased risk of heart attack (myocardial infarction).
The occurrence of side effects can be reduced by taking the medicine in the smallest effective dose and for no longer than necessary.
Do not exceed the recommended dose and duration of treatment.
Allergic reactions, including angioedema and severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported with the use of Biofenac. The risk of skin reactions is higher during the first month of treatment. At the first sign of a skin rash, mucosal damage, or any signs of hypersensitivity, treatment should be discontinued and medical attention should be sought immediately (see section 4).
Treatment with Biofenac should be discontinued in case of the first signs of skin rash or other signs of hypersensitivity.
Biofenac should not be used in case of chickenpox.
Biofenac may rarely cause gastrointestinal ulcers and bleeding. This can occur at any time during treatment, with or without warning symptoms.
In case of observing any abdominal symptoms, especially in the elderly, contact your doctor.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Some medicines may affect the action of Biofenac. In such cases, it may be necessary to change the dose or discontinue the use of these medicines. This is especially important if you are taking:
Biofenac can be taken with or without food.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Tell your doctor if you are planning to become pregnant or if you have problems getting pregnant.
NSAIDs may make it more difficult to become pregnant.
Do not take Biofenac if you are in the last three months of pregnancy, as it may harm your unborn baby or cause problems during delivery. Biofenac may cause problems with the kidneys and heart of the unborn baby. Biofenac may affect the ability to clot and cause prolonged delivery. Do not take Biofenac during the first 6 months of pregnancy, unless your doctor considers it absolutely necessary. If it is necessary to take the medicine during this period or when planning to become pregnant, use the lowest possible dose for the shortest possible time. Taking Biofenac for more than a few days from the 20th week of pregnancy may cause kidney problems in the unborn baby, leading to low levels of amniotic fluid surrounding the baby (oligohydramnios) or narrowing of the blood vessel (ductus arteriosus) in the baby's heart. If you need treatment for a longer period, your doctor may recommend additional check-ups.
Treatment with this medicine during any pregnancy period should be done under medical supervision.
It is not known whether Biofenac passes into breast milk. Breastfeeding is not recommended, unless your doctor decides otherwise.
Do not drive or operate hazardous machinery if you experience dizziness, nausea, or other central nervous system disorders while taking Biofenac.
The medicine contains less than 1 mmol (23 mg) of sodium per coated tablet, which means it is essentially 'sodium-free'.
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Swallow the tablets whole with a sufficient amount of liquid.
The recommended daily dose is200 mg, i.e., one coated tablet in the morning and one in the evening (one coated tablet every 12 hours).
If you feel that the effect of Biofenac is too strong or too weak, consult your doctor or pharmacist.
The use of Biofenac is not recommended in children due to the lack of data on efficacy and safety.
Dosage will be determined by your doctor. Regular check-ups will be necessary.
Dosage will be determined by your doctor. Regular check-ups will be necessary.
The recommended initial daily dose should be reduced to one coated tablet per day.
In case of long-term use of Biofenac, your doctor will regularly perform laboratory tests (blood morphology, liver and kidney function tests).
Contact your doctor or pharmacist immediately or go to the nearest hospital emergency department. Take this leaflet with you!
Do not worry! Do not take a double dose to make up for a forgotten tablet. Take the next dose at the usual time.
The duration of treatment is determined by your doctor. Do not stop treatment prematurely, even if you feel better.
If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Most of them are mild and disappear after stopping treatment with Biofenac.
Side effects may occur with the following frequencies, defined below:
Allergic reactions, including anaphylactic shock and angioedema (rare) with symptoms such as:
Ulcers and bleeding from the gastrointestinal tract (rare) with symptoms such as:
Potentially life-threatening skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis (very rare) with symptoms such as:
Common:dizziness, indigestion (upset stomach), abdominal pain, nausea, diarrhea, and changes in liver function tests.
Uncommon:bloating (gas), gastritis (inflammation of the stomach lining), constipation, vomiting, oral ulcers, itching, and rash.
Rare:high blood pressure, heart failure, shortness of breath (difficulty breathing or shortness of breath, usually associated with certain heart or lung diseases, also known as lack of breath), anemia (low red blood cell count or low hemoglobin level), vision disturbances.
Very rare:abnormally low white blood cell count and platelet count, elevated potassium levels, and elevated liver enzyme activity in the blood, depression, sleep disturbances, unusual dreams, paresthesia (tingling sensation), tremors (rhythmic, involuntary movements), headaches, taste disturbances, oral inflammation (inflammation of the oral mucosa), pancreatitis, hepatitis, dizziness (feeling of spinning), tinnitus (feeling of ringing, buzzing, and hearing other sounds without external cause), purpura (numerous small bleeding spots in the skin), rash, edema (swelling of the legs, arms, or face), muscle cramps, kidney function disorders, kidney failure, palpitations (unpleasant feeling of irregular and (or) strong heartbeat), vasculitis (inflammation of blood vessels), fatigue, sudden flushing of the face, hot flashes, breathing difficulties (bronchospasm), weight gain, intestinal perforation, exacerbation of inflammatory bowel diseases (Crohn's disease, ulcerative colitis).
In individual cases, during chickenpox, severe skin infections have been observed.
If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49-21-301
Fax: +48 22 49-21-309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Store the medicine at a temperature below 25°C.
Do not use this medicine after the expiry date stated on the carton and blister after: "EXP". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance of Biofenac is aceclofenac.
Each coated tablet contains 100 mg of aceclofenac.
Core:
Glycerol distearate,
Croscarmellose sodium,
Povidone (K-30),
Microcrystalline cellulose (type 101),
Microcrystalline cellulose (type 102).
Coating:
Sepifilm 752:
Magnesium stearate,
Titanium dioxide (E 171),
Microcrystalline cellulose,
Hypromellose.
Appearance:White, round, biconvex, coated tablets with a diameter of 8 mm, with the inscription "A" on one side, and the other side is smooth.
Pack:20, 60 coated tablets in PA/Aluminum/PVC//Aluminum blisters and a cardboard box.
Not all pack sizes may be marketed.
Marketing authorization holder:
GEDEON RICHTER POLSKA Sp. z o.o.
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
Manufacturer:
Gedeon Richter Plc.
Gyömrői út 19-21
1103 Budapest
Hungary
To obtain more detailed information about the medicine and its names in other EU member states, contact:
GEDEON RICHTER POLSKA Sp. z o.o.
Medical Department
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
Phone: +48 (22)755 96 48
[email protected]
Date of last revision of the leaflet:February 2023
((logo of the marketing authorization holder))
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Biofenac – subject to medical assessment and local rules.